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Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is a multifunctional 
cytokine member of the TNF family. TWEAK binds to its only known receptor, Fn14, 
enabling it to activate downstream signaling processes in response to tissue injury. The 
aim of this study was to investigate the role of TWEAK signaling in neonatal hypoxia–
ischemia (HI). We found that after neonatal HI, both TWEAK and Fn14 expression were 
increased to a greater extent in male compared with female mice. To assess the role of 
TWEAK signaling after HI, the size of the injury was measured in neonatal mice geneti-
cally deficient in Fn14 and compared with their wild-type and heterozygote littermates. 
A significant sex difference in the Fn14 knockout (KO) animals was observed. Fn14 
gene KO was beneficial in females; conversely, reducing Fn14 expression exacerbated 
the brain injury in male mice. Our findings indicate that the TWEAK/Fn14 pathway is 
critical for development of hypoxic–ischemic brain injury in immature animals. However, 
as the responses are different in males and females, clinical implementation depends on 
development of sex-specific therapies.
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inTrODUcTiOn
Hypoxia–ischemia (HI) remains an important etiology of brain injury in term infants suffering from 
intrapartum asphyxia, and in preterms suffering from hypoxic and hypotensive exposures (1, 2). 
Children from both sexes are at risk of developing brain injury; however, sex differences in the 
response to HI especially among preterm children are well described (3–5). Most of the available data 
to date are suggesting that male sex is significant risk factor and male infants are more vulnerable 
to HI insult.
The pathophysiology is complex and multifactorial. Mechanisms such as mitochondrial dysfunc-
tion, oxidative/nitrosative stress, apoptosis, necroptosis, and inflammatory processes are involved 
(6). Experimental data support the concept that components in the immunoinflammatory reaction 
contribute to cell death after HI (7). However, our understanding of which inflammatory mediators 
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induce damage of neurons and oligodendroglia precursor cells 
(OPCs) in neonatal HI is incomplete. It is important to mention 
that inflammatory responses to injury may be different in males 
and females as sex differences in microglial response in various 
neurodevelopment and neurodegenerative disorders have been 
reported (8–10). This difference is likely to contribute to the dif-
ferences in outcome after HI insult observed in clinical studies 
between males and females.
During the inflammatory cascade, infiltrating cells and glial 
cells resident in the brain (part of both the adaptive and innate 
immune system) produce reactive oxygen species, release excito-
toxic amino acids, pro-inflammatory cytokines, and chemokines 
(11, 12). Among the prominent cytokine pathways involved in 
cell death is a subset of the tumor necrosis factor (TNF) family, 
including TNF-α, TNF-β, FasL, TRAIL, and TWEAK (11, 13–17). 
We hypothesized that TNF superfamily members participate in 
the development of injury after HI since several TNF ligand–
receptor pairs have been identified in the injurious cascade (18). 
TNF-α (19) and Fas signaling (13, 20, 21) are already implicated 
in HI brain injury, but there is limited knowledge about the role 
of TWEAK in the evolution of neonatal brain injury.
TWEAK is a ubiquitously expressed cytokine and the only 
confirmed signaling receptor for TWEAK is FGF-inducible 
molecule 14, Fn14 (also called TWEAKR, TNFRSF12A, and 
CD266), although another receptor, CD163, has been reported 
to bind TWEAK (22, 23). Fn14 signaling is mediated by TNF 
receptor-associated factors (24) and has been inferred to regulate 
various physiological processes such as cell proliferation, migra-
tion, survival, differentiation, and death, depending on the cel-
lular context (25).
TWEAK and Fn14 are expressed at low levels in the brain 
under normal conditions (15). However, the TWEAK pathway 
has been implicated in the pathogenesis of several neurologi-
cal conditions such as ischemic stroke and multiple sclerosis 
(15, 26–28). Experiments in rodent adult models of stroke 
showed that inhibition of this pathway by TWEAK neutral-
izing antibody, soluble decoy Fn14-Fc, or genetic deficiency 
(26, 27, 29) significantly reduced brain damage after middle 
cerebral artery occlusion. The beneficial effects of inhibition 
of TWEAK signaling in this model have been attributed to the 
increased blood–brain barrier (BBB) stability, which leads to 
decreased cerebral edema, decreased infiltration of inflamma-
tory cells in the ischemic tissue (30), and decreased neuronal 
death.
The aim of this study was to test the effect of inhibiting 
TWEAK signaling in the context of a neonatal model of HI. Here 
we evaluate changes of the expression of both TWEAK and Fn14 
after HI in mice, and the effect of Fn14 genetic deficiency on the 
development of the brain injury after HI.
MaTerials anD MeThODs
neonatal hi
This study was approved by the KCL animal ethical committee 
(AWERB), and all animal experimentation was performed in 
compliance with the UK Home Office regulations (PPL 70/8376). 
C57BL/6 wild-type (WT) mice were obtained from Charles River 
(UK); Fn14 knockout (KO) animals were obtained from Biogen 
(Cambridge, MA, USA). For the experiments, the homozygote 
KO females were mated with WT C57BL/6 males to produce 
heterozygote offspring, those heterozygote animals were mated 
to produce mixed litters of WT, homo- and heterozygote KO 
animals which we have used in our experiments.
Neonatal HI was induced at postnatal day 9 according to 
methods described by Rice et al. (31), but modified for mice 
(32, 33). Mice of both sexes were anesthetized with isoflurane 
(3% for induction and 1.5% for maintenance) in nitrous oxide/
oxygen (1:1). The left common carotid artery was ligated with 
Prolene suture (6.0). After the surgical procedure, the wounds 
were closed and infiltrated with a local anesthetic. After 1 h 
of recovery with the dam, the pups were placed in a chamber 
perfused with a humidified gas mixture (10% oxygen in nitro-
gen) for 65 min at 36°C. The animals were kept in humidified 
air at 36°C for an extra 10 min before and after the hypoxic 
exposure. After the hypoxia, the pups were returned to their 
dams. This procedure results in brain injury in the ipsilateral 
hemisphere, consisting of cerebral infarction and selective 
neuronal death in the cortex, striatum, hippocampus, and the 
thalamus, leaving the contralateral hemisphere undamaged. 
Sham-operated animals were subjected to isoflurane anesthe-
sia and incision only, without carotid ligation and hypoxia. 
After the HI procedure pups were killed by decapitation at 
various time points. Brains were removed and rapidly frozen 
on dry ice for RNA isolation or fixed in 4% paraformaldehyde 
for immunostaining. In total, 144 animals were used in this 
study, 36 for RT-qPCR analysis (Figures 1A–D), 5 for western 
blot analysis (Figures 1E–H), 3 for fluorescent immunohisto-
chemistry (Figure  2), and 100 for histological evaluation of 
the brain injury (Figures 3–6).
immunohistochemistry
The fixed brains were embedded in blocks of 25 brains, freeze-
sectioned (30 µm) and sections collected at 10 different levels using 
MultiBrain® Technology (NSA Labs, USA). The multibrain sections 
were stained with MBP, Ischemia Contrast, MAP2 and Iba1 (NSA 
Labs, USA). For the fluorescent immunohistochemistry, 5  µm 
paraffin embedded brain sections were prepared, deparaffinized 
with xylene and ethanol, and pretreated with heating for 20 min 
in 10 mM citric acid, pH 6.0 with 0.1% Tween 20. Sections were 
blocked for 20 min with 5% horse serum, 1% BSA in PBS before 
incubation with primary antibodies overnight at 4°C. We used 
rabbit anti-TWEAK (Sigma, UK), rabbit anti-Fn14 (Abcam, UK), 
mouse anti-GFAP (Sigma, UK), mouse anti-Olig2 (Millipore, UK), 
and mouse anti-TUJ1 (Cambridge Bioscience, UK) antibodies. 
Immunohistochemistry controls performed with secondary Ab 
alone (data not shown) or on tissue from Fn14 KO animals with 
anti-Fn14 antibody (Figure S1 in Supplementary Material) showed 
no visible staining. For visualization, we used AlexaFluor488-
conjugated anti-mouse antibody and AlexaFluor546-conjugated 
anti-rabbit antibody (Life Technologies). Sections were analyzed 
using a Leica DM6000 B fluorescent microscope and a Leica TCS 
SP5 confocal microscope. Images were processed using Leica LAS 
AF Lite and ImageJ.
FigUre 1 | Effects of hypoxia–ischemia (HI) on the expression levels of TWEAK (a,c) and Fn14 (B,D) in neonatal mice. mRNA levels were measured in contralateral 
(Contra; white bars) and ipsilateral (Ipsi; gray bars) hemispheres of the brain 4, 24, and 72 h after the insult. The results are expressed as fold change from 
contralateral side. Western blot detection of TWEAK (e) and Fn14 (F) protein and densitometry (g,h) in sham-operated (Sham, white bars), ipsilateral (I, gray bars), 
and contralateral hemisphere (C, black bars) brain lysates 72 h after HI. Densitometry of the TWEAK and Fn14 bands was corrected to the corresponding β-actin 
bands. Bars represent mean + SEM; *p < 0.05; **p < 0.01; versus corresponding contralateral side [n = 6–9 (a–D) and n = 3 (e,F)].
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evaluation of Brain injury
For our analysis, we have used seven coronal levels across each 
brain. Total amount of tissue loss was calculated using ImageJ. 
Briefly, the coronal brain images were segmented by the 
background and threshold for the Ischemia Contrast staining 
applied, the hemispheres were manually segmented and inten-
sity of the immunostaining and area calculated for both 
contralateral and ipsilateral hemisphere. The ipsilateral hemi-
sphere was represented as percentage of uninjured contralateral 
hemisphere.
FigUre 2 | Representative images of confocal (a–D) and conventional  
(e,F) fluorescence microscopy of paraffin sections from contralateral [Contra 
(a,c,e)] and ipsilateral [Ipsi (B,D,F)] hemispheres of the wild-type mouse 
brain at 72 h after hypoxia–ischemia. There was TWEAK immunoreactivity 
(red) in GFAP-positive (green) astroglia (a,B) and Fn14 immunoreactivity  
(red) in TUJ-positive (green) neurons (c,D) and Olig2-positive (green) 
oligodendrocytes (e,F). Scale bar = 10 µm (a–D) and 30 µm (e,F).
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Brain injury in different regions was also evaluated by an 
observer blinded to the study groups, using a semi quantitative 
neuropathological scoring system (32). Injury in the cerebral cor-
tex was graded both with respect to hypotrophy (0–3) and injury/
infarction (0–4; with 0 being no observable injury and 4 being 
confluent infarction encompassing most of the hemisphere). The 
damage in the hippocampus, striatum, and thalamus was assessed 
regarding both hypotrophy (shrinkage) (0–3) and observable cell 
injury/infarction (0–3), resulting in a neuropathological score for 
each brain region (0–6) except for cerebral cortex 0–7. The total 
score (0–25) was the sum score for all four regions.
evaluation of Microglia injury
For our analysis, we have used seven coronal levels across 
each brain. Total amount of Iba1 staining was calculated using 
ImageJ. Briefly, the coronal brain images were segmented by the 
background and threshold for the immunostaining applied, the 
hemispheres were manually segmented and the immunostaining 
area calculated for both contralateral and ipsilateral hemisphere. 
The area of positive Iba1 staining was calculated as percent of 
hemisphere area. The ipsilateral hemisphere was represented as 
percentage difference compared with uninjured contralateral 
hemisphere.
rna isolation
Total RNA from mouse brains was isolated using the RNeasy mini 
kit (Qiagen) according to the manufacturer’s instructions.
Quantitative rT-Pcr (qrT-Pcr)
The reverse transcription reaction was performed using High 
Capacity cDNA reverse transcription kit (Applied Biosystems) 
according to the manufacturer’s instructions. qRT-PCR experi-
ments were performed using the StepOnePlus™ Real-Time PCR 
Systems, TaqMan probes and TaqMan Gene Expression Master 
Mix (Applied Biosystems). All reactions were conducted in dupli-
cate and corrected to GAPDH expression. Data were analyzed 
using the delta threshold cycle (CT) method (34).
Western Blot
30  µg total protein lysate per sample was separated by electro-
phoresis using 10% Bis–Tris NuPAGE® Novex gels (Invitrogen) 
and XCell SureLock® Mini-Cell (invitrogen). Proteins were trans-
ferred to polyvinylidene fluoride membranes using iBlot® Gel 
Transfer Device (Invitrogen). Membranes were blocked with 5% 
non-fat dry milk in Tris-buffered saline containing 0.1% Tween 20 
(TBS-T) and immunoblotted overnight at 4°C with anti-TWEAK 
antibody (sigma) or anti-Fn14 antibody (abcam) diluted 1:2,500 
in TBS-T. After washing with TBS-T, membranes were incubated 
for 1 h with HRP conjugated anti-goat antibody at room tempera-
ture. Membranes were washed with TBS-T and developed with 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Life 
Science, City, State). The images were taken with ImageQuant™ 
LAS4000 digital imaging system (GE). Density of the bands was 
analyzed using FIJI (ImageJ), and the TWEAK and Fn14 bands 
were corrected to the corresponding β-actin bands.
statistical analysis
The size of samples for our study was calculated using the follow-
ing formula n = (Zα/2 + Zβ)2*2σ 2/δ2, where Zα/2 is significance 
level; Zβ is power; σ is SD of variable, and δ is minimum impor-
tant difference. For this study, we have chosen significance level 
of 5% and power 80%.
The statistical analysis was performed using Prism GraphPad 
5.0 software (GraphPad Software). Data are expressed as 
mean ±  SEM. Comparisons between the experimental groups 
were made using one-way analysis of variance (ANOVA) fol-
lowed Tukey posttest for comparing between more than two 
groups with one independent factor (Figures  1G,H) or using 
two-way ANOVA followed by Bonferroni posttest for comparing 
between more than two groups with two independent factors 
(Figures 1A–D, 3, 4, 5 and 6).
resUlTs
neonatal hi increases expression  
of TWeaK and Fn14
The expression of TWEAK and Fn14 was evaluated in a neonatal 
mouse model of HI. We found a significant increase in TWEAK 
FigUre 3 | Male Fn14 knockout (KO) mouse pups were more severely injured after hypoxia–ischemia (HI) than females. Brain sections (seven different levels) were 
generated 7 days after HI and subjected to Ischemia Contrast staining (a). Tissue loss in the ipsilateral side is presented as % loss compared with contralateral 
across seven levels studied. Bars represent mean + SEM (***p < 0.001, comparison between male and female. ##p < 0.01 and ###p < 0.001 for comparison of 
different genotypes in the same sex group). (B,c) Representative images of brain sections from female (B) and male mice (c) with wild-type (WT) and FN14 KO 
genotype stained with Ischemia Contrast staining. These images are selected from an animal with tissue loss closest to the average tissue loss for the group.  
The percent of the tissue loss is indicated below each brain section. WT (white bars), Het (gray bars), and KO (black bars).
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FigUre 4 | Male Fn14 knockout (KO) mouse pups lost more white matter after hypoxia–ischemia (HI) than females. Brain sections (seven different levels) were 
generated 7 days after HI and subjected to myelin basic protein (MBP) staining (a). MBP loss in the ipsilateral side is presented as % loss compared with 
contralateral. Bars represent mean ± SEM (***p < 0.001, comparison between male and female. #p < 0.05 and ##p < 0.01 for comparison of different genotypes in 
the same sex group). (B,c) Representative images of brain sections from female (B) and male mice (c) with wild-type (WT) and FN14 KO genotype stained with 
MBP. These images are selected from an animal with MBP staining closest to the average for the group. WT (white bars), Het (gray bars), and KO (black bars).
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mRNA levels in the ipsilateral compared with the contralateral 
hemisphere of male pups at the time points of 24 and 72 h after HI 
(Figure 1A). In the brains of female animals, we found a similar 
pattern in TWEAK expression in the ipsilateral side at 72 h after 
HI that did not reach significance (p = 0.052; Figure 1C). Fn14 
mRNA expression was significantly induced at 4  h after HI in 
male animals and 24 h after HI in both male and female animals 
(Figures 1B,D). Unlike TWEAK where expression increased over 
FigUre 5 | No sex differences were observed in microglia number after hypoxia–ischemia (HI). Brain sections (seven different levels) were generated 7 days after HI 
and subjected to Iba1 staining (a). Microglial staining in ipsilateral side is presented as percent difference from contralateral side. No significant differences were 
observed (B,c). Representative images of brain sections from female (B) and male mice (c) with wild-type (WT) and FN14 knockout (KO) genotype stained with 
Iba1. These images are selected from an animal with Iba1 staining closest to the average for the group.
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time, with highest values at 72 h, Fn14 expression peaked at 24 h 
and normalized 72 h after HI. At all the time points studied, no dif-
ferences in TWEAK and Fn14 expression were observed between 
samples from contralateral compared with sham-operated ani-
mals as well as no difference in expression of TWEAK and Fn14 
in males versus females in the contralateral hemisphere. Protein 
FigUre 6 | Effect of the genotype on the neuropathological score of the brain after hypoxia–ischemia (HI) in neonatal model of brain injury. Neuropathological 
scores were assessed from four different brain regions (seven levels generated at 7 days after HI, as above) subjected to Ischemia Contrast and MAP2 staining.  
The sum of the scores from cerebral cortex (a), hippocampus (B), striatum (c), and thalamus (D) were combined for a total score (e). Bars represent mean ± SEM 
(***p < 0.001, comparison between male and female. #p < 0.05; ##p < 0.01; and ###p < 0.001 for comparison of different genotypes in the same sex group). Wild 
type (WT) (white bars), Het (gray bars), and knockout (KO) (black bars).
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expression was analyzed by western blot of brain lysates prepared 
at 72 h post insult. As observed with the mRNA results, TWEAK 
and Fn14 protein expression were significantly increased in the 
ipsilateral hemisphere after HI (Figures 1E–H).
To investigate which cells were responsible for the enhanced 
expression of TWEAK and Fn14, we analyzed brain sections 
by immunofluorescence from animals sacrificed 72  h after HI. 
TWEAK immunofluorescence was strongest in GFAP+ astrocytes 
in the ipsilateral hemisphere (Figures 2A,B); no co-localization 
of TWEAK was observed in neurons, microglia, or oligoden-
drocytes (data not shown). By contrast, Fn14 was expressed in 
neurons (Figures 2C,D) and in oligodendroglial precursor cells 
(Figures 2E,F) 72 h after HI. Expression was not observed in any 
other cell type (data not shown).
9Kichev et al. HI sex differences in Fn14-KO
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Fn14 gene Deletion is Protective in 
Females but augments Brain injury in 
Males after hi
To examine the impact of TWEAK signaling on the evolution 
of brain injury, we subjected mice genetically deficient in Fn14 
(Fn14 KO) to our neonatal HI protocol and determined the effect 
of gene KO on brain injury. We found no significant difference in 
the tissue loss between the female and male WT or heterozygote 
(Het) animals. However, in female Fn14 KO mice, mean tissue 
volume loss was significantly reduced compared with WT and Het 
females [21.3 ± 2.8% in KO females compared with 38.1 ± 2.0 and 
41.0 ± 1.4% in WT and Het females, respectively (Figures 3A,B)]. 
Surprisingly, brain injury was consistently more pronounced in 
male Fn14 KO compared with WT and Het males [47.5 ± 1.7% in 
the KO males compared with 33.5 ± 2.0 and 39.6 ± 1.4% in WT 
and Het males, respectively (Figures 3A,C)]. Thus, there was a 
differential effect of Fn14 deficiency in female versus male KO 
mice. To investigate this differential effect further, we analyzed 
potential changes in white matter [myelin basic protein (MBP)] 
as well as microglial infiltration (Iba1) after HI injury (Figures 4 
and 5). MBP staining was conserved in female Fn14 KO mice 
(Figures  4A,B), indicating increased white matter integrity, 
whereas there was a trend toward loss of MBP staining in male 
Fn14 KO, although this did not reach significance (Figures 4A,C). 
There were also no significant differences between the genotypes 
as well as between males and females observed in the sections 
stained for Iba1 (Figures 5A–C).
Finally, we carried out a detailed analysis of neuropathology 
scores associated with injury to specific brain regions. In line with 
our previous observations, we observed differential responses 
between male and female sections in cerebral cortex (Figure 6A), 
hippocampus (Figure 6B), striatum (Figure 6C), and thalamus 
(Figure 6D). In all regions examined, deletion of Fn14 was associ-
ated with attenuation of brain injury in females and increased 
injury in the male brain (Figure 6).
To discard the possibility of any differences in the brain volume, 
myelin content, or microglia numbers between males and females 
and between different genotype groups, we have analyzed and 
compared contralateral sides of all brains stained with Ischemia 
Contrast, MBP and Iba1 (Figure S2 in Supplementary Material). 
We found no significant differences indicating that all differences 
found in the ipsilateral side were a result of the differences in 
brain injury.
DiscUssiOn
In this study, we report a sex difference in neonatal HI where 
Fn14 deletion decreased injury in females and increased injury in 
males. We have shown that the expression of both TWEAK and 
its receptor Fn14 is increased in the injured side of the brain after 
HI in vivo and that the increased expression of TWEAK appears 
to be due to its expression in activated astrocytes. The increase of 
Fn14 expression was detected mainly in neurons and OPC proxi-
mal to the injury site. As neurons and oligodendrocytes are the 
main cell types lost after HI (35), this may suggest involvement 
of TWEAK signaling in the development of neonatal brain injury 
after HI. We also found a marked sex difference in the response to 
partial or complete Fn14 gene deficiency. In females, brain tissue 
loss after HI was reduced in Fn14 KO mice whereas gene deletion 
worsened injury in the males (Figures 3A, 4, 5 and 6). Existence 
of sex differences in the response to HI especially among preterm 
children is well described (3–5). Sex differences have been shown 
in HI experiments with neonatal WT mice, where males exhibit 
more severe brain injury than females (36), although studies using 
this model do not always find a difference in the extend of brain 
injury (37, 38). A more common finding is sex-specific responses 
to various treatments in neonatal animal models, where male and 
female pups respond differently to treatments administered after 
injury implicating that different injury mechanisms are at play 
(37, 39–44). In adult, it is well known that gonadal hormones 
such as estrogen and progesterone exert protective effect (45, 46). 
However, in neonatal animals, hormonal influences are less 
likely to contribute but sex-dependent basic cellular and genetic 
mechanisms seem to be critical (5).
The interesting finding in our study is that Fn14 deficiency has 
an effect on both sexes but is in opposite directions for males and 
females. The differences that we observed were consistent in all 
brain areas examined (cerebral cortex, hippocampus, striatum, 
and thalamus) suggesting that no specific area accounts for the 
difference but rather a consistent effect across the whole brain.
We currently cannot provide an explanation regarding why 
TWEAK–Fn14 signaling increases injury in females whereas it 
is part of a protective response in males. From our experiments, 
in WT animals, it is obvious that male animals responded 
differently to HI with an earlier increase in the expression of 
TWEAK and Fn14 than the females (Figures  1A–D). We and 
others have previously found differences in the intrinsic apoptotic 
pathway between males and females (37, 42, 43). It appears that 
the poly(ADP-ribose) polymerase 1 and apoptosis-inducing 
factor are more critical components in the caspase-independent 
apoptotic cascade in neurons of males whereas those of females 
depend more on the cytochrome C–caspase pathway (37). We can 
speculate that there are also sex differences in the death receptor 
pathway that may relate either to the extrinsic apoptotic pathway 
or RIP1 kinase-dependent necroptosis. The latter has previously 
been shown to be different in male and female mice after neonatal 
HI (44). TWEAK treatment induces cell death in primary cortical 
neurons through NF-κB pathway activation (26, 47). However, 
NF-κB activation downstream of death receptor activation has 
been suggested to play a role both in cell survival and cell death 
depending on context (16, 48), which certainly could be different 
between the male and female CNS.
Another possible explanation for the sex difference is that 
TWEAK exerts its neurotoxicity on the neurons and oligoden-
drocytes not directly through activating their Fn14 receptors 
but indirectly by changing their environment, for example, 
through effects on BBB permeability, as observed in adult models 
of HI injury (30). TWEAK signaling is able to activate matrix 
metalloproteinase-9 activity in the brain and in primary astro-
cytes, which in turn increases the permeability of the BBB (49). 
If the BBB is compromised, this will allow the influx of immune 
cells from the blood, as well as of inflammatory cytokines and 
infectious agents, into the brain. In such a case, the state of 
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peripheral inflammatory cells may have a profound effect on the 
development of brain injury.
We examined the amount of Iba1 positive cells in the brains 
after HI injury to study whether the sex differences in the injury 
can be attributed to differences in the microglial immune res-
ponse. Sex differences in microglial response have been reported 
in various neurodevelopment and neurodegenerative dis orders 
(8–10). In our study, we have limited our investigation on micro-
glia only to Iba1 staining, which is an estimate for the number of 
microglia cells rather than their inflammatory status (e.g., secre tion 
of cytokines, phagocytosis, etc.). We did not detect any significant 
difference in our experiment (Figure 5), meaning that the increase 
in the number of microglia cell after HI is equal in male and 
female as well as in different genotypes.
Sex differences in the inflammatory response of astrocytes to 
inflammation-inducing agents like lipopolysaccharide has been 
reported (50). This makes astrocytes and their interaction with the 
neurovascular unit a reasonable candidate for future studies on 
the sex-dependent role of TWEAK/Fn14 in perinatal brain injury.
More studies are needed to determine whether the sex differ-
ences between male and female KO animals can be attributed to 
differences in the inflammatory response and/or BBB permeability. 
The other receptor for TWEAK, CD163, is unlikely to contribute 
for any of the physiological effects observed in our study. CD163 
is a scavenger receptor for hemoglobin and haptoglobin without 
intracellular signaling (51). Moreover, some studies were unable 
to find any interaction of TWEAK with CD163 (52). A certain 
degree of promiscuity can be anticipated as it is well known that 
the members of TNF family have significant structural similarity 
to each other and it is common that one ligand is signaling through 
multiple receptors (TNF-α can bind to both TNFR1 and TNFR2; 
TRAIL can bind to five different receptors in human, etc.). It is not 
unlikely, however that TWEAK is interacting with and signaling 
through receptors undescribed to date as a binding partner of 
TWEAK. Therefore, TWEAK that is present in high concentrations 
after HI (Figure 1A) could easily bind to other receptors with much 
lower affinity and trigger some cellular responses. However, to date 
no alternative binding partners of TWEAK are currently described.
In this study, we have found increase in the expression levels in 
both TWEAK and Fn14 in the ipsilateral side of the brain follow-
ing HI and an opposite effect of the Fn14 deletion on the develop-
ment of the injury for the males and females. These findings are 
opening different avenues for further investigation of the effects of 
TWEAK/Fn14 signaling in the context of perinatal brain injury.
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FigUre s1 | Representative images of confocal (a,B) and conventional  
(c,D) fluorescence microscopy of paraffin sections from wild type [WT  
(a,c)] and Fn14 knockout [Fn14 KO (B,D)] of the mouse brain. There was  
Fn14 immunoreactivity (red) in TUJ-positive (green) neurons (a) and Olig2-
positive (green) oligodendrocytes (c) in the WT animals. Lack of any Fn14 
staining in Fn14 KO animals (B,D). Scale bar = 10 µm (a,B) and 30 µm (c,D).
FigUre s2 | No difference in total brain tissue (a), myelin basic protein (MBP) 
staining (B), and Iba1 staining (c) between males and females and between 
wild-type (WT), Fn14 knockout (KO), or heterozygote (Het) animals. Brain 
sections (seven different levels) were generated 7 days after hypoxia–ischemia 
and subjected to Ischemia Contrast staining (a), tissue area in the contralateral 
side was measured and presented as square millimeters. MBP immunostaining 
(B) and Iba1 immunostaining (c) of the contralateral side are presented as 
percentage of total brain area of the contralateral side. Bars represent 
average + SEM.
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